BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
Its mechanisms are broad and systemic, meaning it can benefit tissues throughout the body
Mechanism of Action Comparison# BPC-157# BPC-157 (Body Protection Compound-157) exerts its healing effects through multiple interconnected pathways
No needles, no preparation, no refrigeration in most cases
Scientists isolated this peptide and discovered its healing effects extend far beyond the gutit promotes repair and regeneration in muscles, tendons, ligaments, bones, and other tissues throughout the body
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Modulation Enhances VEGFR2 expression and downstream angiogenesis : BPC-157 induces rapid angiogenesis in granulation tissue via VEGFR2-associated mechanisms, promoting organized capillary formation and increased vascular density in wound regions 1-3